CounterPath (NASDAQ:CPAH) Shares Pass Below 200-Day Moving Average of $1.30

Share on StockTwits

CounterPath, Corp. (NASDAQ:CPAH) (TSE:CCV) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.30 and traded as low as $1.09. CounterPath shares last traded at $1.10, with a volume of 119 shares trading hands.

The company has a debt-to-equity ratio of 1.64, a current ratio of 0.65 and a quick ratio of 0.65. The company’s 50 day simple moving average is $1.12 and its two-hundred day simple moving average is $1.30.

A hedge fund recently raised its stake in CounterPath stock. Wedbush Securities Inc. boosted its position in shares of CounterPath, Corp. (NASDAQ:CPAH) (TSE:CCV) by 72.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 28,192 shares of the software maker’s stock after purchasing an additional 11,874 shares during the period. Wedbush Securities Inc. owned 0.47% of CounterPath worth $32,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 1.36% of the company’s stock.

About CounterPath (NASDAQ:CPAH)

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. Its products include Bria softphone suite, which enables consumers and business users to make voice over Internet protocol (VoIP) audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and X-Lite, a standards-based VoIP softphone application that runs on desktop computers.

Read More: What is intrinsic value?

Receive News & Ratings for CounterPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.